Key terms
About NRXP
NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded on September 18, 2017 and is headquartered in Wilmington, DE.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest NRXP news
Apr 17
4:47pm ET
NRx Pharmaceuticals announces common stock offering, no amount given
Apr 17
8:35am ET
NRx Pharmaceuticals announces new data on NRX-101
Apr 15
8:34am ET
NRx Pharmaceuticals develops new proprietary formulation of HTX-100
Apr 08
8:32am ET
NRx Pharmaceuticals achieves data-lock of Phase 2b/3 trial of NRX-101
Apr 01
7:50pm ET
NRX Pharmaceuticals trading halted, news pending
Mar 31
2:01am ET
Navigating the Minefield: Nrx Pharmaceuticals’ Tightrope Walk Between Safety Regulations and Operational Hazards
Mar 28
5:22pm ET
NRX Pharmaceuticals Announces Reverse Stock Split
Mar 28
8:08am ET
NRx Pharmaceuticals sees FY23 EPS (40c), consensus (37c)
Mar 28
8:05am ET
NRx Pharmaceuticals announces 1-for-10 reverse stock split
Mar 21
5:22pm ET
NRX Pharmaceuticals Shareholders Approve Potential Reverse Split
Mar 18
8:36am ET
NRx Pharmaceuticals announces plan to distribute shares of HOPE Therapeutics
Mar 12
7:51am ET
NRx Pharmaceuticals initiates strategy to combat short sales
Mar 11
8:35am ET
NRx Pharmaceuticals completes MOU with distribution partners for HTX-100
Mar 04
8:37am ET
NRx Pharmaceuticals: Last patient, last visit in Phase 2b/3 trial of NRX-101
Mar 01
8:35am ET
NRx Pharmaceuticals announces $1M purchase agreement
Feb 26
4:03pm ET
NRx Pharmaceuticals announces common stock offering, no amount given
Feb 26
8:35am ET
NRx Pharmaceuticals launches HOPE Therapeutics at BIO Conference
Feb 14
4:45pm ET
NRX Pharmaceuticals Amends Repayment Terms with Streeterville Capital
Feb 12
8:33am ET
NRx Pharmaceuticals receives $5M milestone payment
Feb 09
8:33am ET
NRx reports comments from its partner Lotus on its recent financial filing
Feb 05
7:04am ET
NRx Pharmaceuticals announces incorporation of Hope Therapeutics
Jan 22
2:09pm ET
Buy Rating Affirmed for NRX Pharmaceuticals Amid Promising Outlook for Novel Depression Treatment NRX-100
Jan 22
6:53am ET
NRx Pharmaceuticals completes enrollment in NRX-101 study
No recent press releases are available for NRXP
NRXP Financials
Key terms
Ad Feedback
NRXP Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
NRXP Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
